Background The recent pandemic of coronavirus disease 2019 (COVID-19) has resulted in
many challenges to the healthcare organizations around the world. Unfortunately, until now …

Poor statistical reporting: do we have a reason for concern? A narrative review and
recommendations Page 1 ACI 240401 CURRENT OPINION Poor statistical reporting: do we …

The coronavirus disease of 2019 (COVID-19) has caused significant morbidity and mortality
among infected individuals across the world. High transmissibility rate of the causative virus …

Objective To assess the efficacy of Favipiravir compared to the standard therapy in treating
patients with severe COVID-19 infection. Methods This is a retrospective cohort of patients …

Abstract Coronavirus disease (COVID-19) was first reported in December 2019, China and
later it was found that the causative microorganism is severe acute respiratory syndrome …

We are presenting an overview of the retracted clinical trials about the Coronavirus Disease
(COVID)-19 published in PubMed using the descriptors ((COVID-19 OR SARS-CoV-2) AND …

The COVID-19 pandemic has reached over 100 million worldwide. Due to the multi-targeted
nature of the virus, it is clear that drugs providing anti-COVID-19 effects need to be …

Conjugates of the natural alkaloid (a R, 7 S)-colchicine with bicyclic monoterpenoids and
their derivatives were synthesized for the first time. Molecular docking of the synthesized …

This work was performed by the importance of exploring possible medications for COVID-19
pandemic. In this regard, cytidine (Cyd) derivatives were investigated to reach a point to see …

Therapeutic agents being designed against COVID-19 have targeted either the virus directly
or the host cellular machinery. A particularly attractive host target is the ubiquitous and …